Boston, MA 10/16/2013 (wallstreetpr) –
Molycorp Inc (NYSE:MCP) announced today that the company intends to offer and sell up to $0.200 billion of its common stock (or up to an aggregate of $0.230 billion of Common Stock if the underwriters exercise their option to buy additional shares of Common Stock in full) in a registered public offering, which is subjected to the market and other conditions. The company has decided to use the net proceeds which have been received from the offering to provide money for current capital needs, for capital expenditures, and other money requirements that includes capital expenditures at its Mountain Pass, California facility, without any limitation. The companies, Morgan Stanley & Co. LLC, J.P. Morgan Securities LLC, and Goldman, Sachs & Corporation will act as joint book runners for the offering.
The offering may be made only with the help of an accompanying prospectus and a prospectus supplement. The copies of the accompanying prospectus and the preliminary prospectus supplement, relating to the Offering may be received from Goldman, Sachs & Co., Prospectus Department, in 200 West Street, New York and from Morgan Stanley & Co. LLC in 180 Varick Street, Second Floor, New York in Prospectus Department and also from J.P. Morgan Securities LLC c/o, 1155 Long Island Avenue, Edgewood in New York.
The news release does not provide a solicitation of an offer to buy or an offer to sell any common stock or other securities, nor there will be any sale of the common stock or other securities in any jurisdiction or state in which such a solicitation, sale, or offer is not allowed. A registration statement has been filed with the Securities and Exchange Commission, which is related to the common stock and is effective.
The statements in the news release regarding current beliefs and expectations of Molycorp as to the consummation of the offering are forward-looking statements. They are not historical facts.
